Image

Global Biomarkers Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Jul 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Biomarkers Market, By Type (Safety, Efficacy, Validation), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease-Risk Assessment, Others), Product Type (Consumables, Services, Software), Technology (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others) – Industry Trends and Forecast to 2029

Biomarkers Market

Biomarkers Market Analysis and Size

Biomarkers are utilized for seeing how well the body responds to a treatment for a condition or disease. These biomarkers are known as signature molecule and molecular marker. The increase in the prevalence of cancer is rising the demand for biomarkers.

Global Biomarkers Market was valued at USD 43.13 million in 2021 and is expected to reach USD 153.34 million by 2029, registering a CAGR of 14.90% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Biomarkers are referred to as minimally or non-invasive tools. These are integrated with key imaging and data management technologies. These tools are widely utilized in imaging technology to provide clear imaging of oncology tumors and other problems. Biomarkers reduce the chance of radiation exposure during imaging through MRI scan and CT scan.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Forecast Period

2022 - 2029

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Safety, Efficacy, Validation), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease-Risk Assessment, Others), Product Type (Consumables, Services, Software), Technology (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Enzo Biochem Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), PerkinElmer Inc. (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Bruker (US), Epigenomics AG (Germany), MESO SCALE DIAGNOSTICS, LLC (US), EKF Diagnostics Holdings plc (UK), General Electric Company (US), Nexus-Dx (US), LifeSign LLC (US), F. Hoffmann-La Roche Ltd (Switzerland), among others

Biomarkers Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

  • Prevalence of Cancer

The increase in the prevalence of cancer across the globe acts as one of the major factors driving the growth of biomarkers market.

  • Funds and Grants

The surge in investments in the form of funds and grants for biomarker research accelerate the market growth.

  • Diagnostic Biomarker Technology

The inclination from conventional approach of pathophysiology/epidemiology to biomarker studies due to the technological advances further influence the market.

Opportunities

Furthermore, increase in demand for personalized medicine extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, continuous product innovation will further expand the market.

Restraints/Challenges

On the other hand, the high capital investments and lengthy timelines for biomarker development are expected to obstruct market growth. Also, technical issues related to sample collection and storage are projected to challenge the biomarkers market in the forecast period of 2022-2029.

This biomarkers market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on biomarkers market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Biomarkers Market

Covid-19 had a positive impact on the biomarkers market. The increase in the number of COVID-19 accelerated the development of the biomarker technologies. Chinese research team pinpointed SARS-CoV-2 coronavirus infection from the molecular markers in the blood that are predictive of acute COVID-19. The biomarkers have become essential in clinical decision making for numerous infectious diseases treatment procedures.

Recent Development

  • F. Hoffmann-La Roche Ltd. launched two cardiac biomarker tests for N-terminal pro-brain natriuretic peptide test (NT-proBNP) and high sensitive cardiac troponin T (cTnT-hs) in April’2021. The cardiac biomarkers assist clinicians in diagnosing heart attacks and manage heart failure better.
  • QIAGEN N.V. (Netherlands) launched first FDA-approved tissue companion diagnostic, therascreen KRAS RGQ PCR Kit in May’2021. The diagnostics will identify the KRAS G12C mutation in NSCLC tumors and expand precision medicine options.

Global Biomarkers Market Scope and Market Size

The biomarkers market is segmented on the basis of type, application, product type, technology and indication. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Safety
  • Efficacy
  • Validation

On the basis of type, the biomarkers market is segmented into safety, efficacy and validation.

Application

  • Diagnostics Development
  • Drug Discovery and Development
  • Personalized Medicine
  • Disease-Risk Assessment
  • Others

On the basis of application, the biomarkers market is segmented into diagnostics development, drug discovery and development, personalized medicine, disease-risk assessment and others.

Product Type

  • Consumables
  • Services
  • Software

On the basis of product type, the biomarkers market is segmented into consumables, services and software.

Technology

  • Safety Biomarkers
  • Efficacy Biomarkers
  • Validation Biomarkers

On the basis of technology, the biomarkers market is segmented into safety biomarkers, efficacy biomarkers and validation biomarkers.

Indication

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Immunological Disorders
  • Others

On the basis of indication, the biomarkers market is segmented into cancer, cardiovascular disorders, neurological disorders, immunological disorders and others.

Biomarkers Market Regional Analysis/Insights

The biomarkers market is analysed and market size insights and trends are provided by country, type, application, product type, technology and indication as referenced above.

The countries covered in the biomarkers market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the biomarkers market because of the high use of biomarkers in personalized medicine within the region.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increased CVD disease in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The biomarkers market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for biomarkers market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the biomarkers market. The data is available for historic period 2010-2020.

Competitive Landscape and Biomarkers Market Share Analysis

The biomarkers market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to biomarkers market.

Some of the major players operating in the biomarkers market are Enzo Biochem Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), PerkinElmer Inc. (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Bruker (US), Epigenomics AG (Germany), MESO SCALE DIAGNOSTICS, LLC (US), EKF Diagnostics Holdings plc (UK), General Electric Company (US), Nexus-Dx (US), LifeSign LLC (US), F. Hoffmann-La Roche Ltd (Switzerland), among others.

Research Methodology: Global Biomarkers Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

Global Apheresis Market is expected to witness CAGR of 14.90% during the forecast period of 2022-2029
The increase in the prevalence of cancer, surge in investments and diagnostic biomarker technologyare the major factors expected to enhance the growth rate of Biomarkers Market.
The major players operating in the biomarkers market are Enzo Biochem Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), PerkinElmer Inc. (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Bruker (US), Epigenomics AG (Germany), MESO SCALE DIAGNOSTICS, LLC (US), among others.
The Countries Covered in the Biomarkers Market Report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.